Severe inclusion body myositis with interstitial pneumonia

Internal Medicine

Volumn 40, Issue 9, 2001, Pages 940-944

  Mori, S ^a   Hamada, H ^a   Yokoyama, A ^a   Kohno, N ^a   Kondo, K ^a   Hara, Y ^a   Kawata, H ^a   Hiwada, K ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD8; Immunosuppressive agent; Inflammatory myositis

Indexed keywords

CD8 ANTIGEN; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

AGED; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCLUSION BODY MYOSITIS; INTERSTITIAL PNEUMONIA; MALE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY;

EID: 0034793436     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.940     Document Type: Article

References (18)

1. Inclusion body myositis
2. Inclusion body myositis
3. Oculopharyngeal muscular dystrophy and distal myopathy. Intrafamilial difference in the onset and distribution of muscular involvement
4. Inclusion body myositis: Clinical and histopathological features of 36 patients
5. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogenous patient groups
6. Inclusin body myositis. Observasions in 40 patients
7. Inclusion body myositis associated with systemic sarcoidosis
8. Inclusion body myositis: A case with associated collagen vascular disease responding to treatment
9. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia
10. Laboratory manifestations of polymyositis/dermatomyositis
11. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis
12. Treatment of autoimmune diseases with intravenous gammaglobulin
13. Drug therapy of the idiopathic inflammatory myopathies: Predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy
14. Inclusion body myositis responding to longterm chlorambucil treatment
15. Inclusion body myositis: Analysis of 32 cases
16. Inclusion body myositis and systemic lupus erythematosus
17. Severe acute form of adult dermatomyositis treated with cyclosporine
18. Update on therapy for refractory dermatomyositis and polymyositis